Dimorphic histopathology of long-standing childhood-onset diabetes
暂无分享,去创建一个
S. Bonner-Weir | A. Steck | M. Atkinson | B. Hering | G. Eisenbarth | S. Kent | C. Wasserfall | A. Pugliese | K. Coppieters | M. Campbell-Thompson | M. Herrath | R. Gianani | S. Sarkar | J. M. Solís | B. Hering | E. West
[1] P. Froguel,et al. Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes. , 2009, Pediatric endocrinology reviews : PER.
[2] M. Peakman,et al. Post‐mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the β cell , 2009, Clinical and experimental immunology.
[3] M. P. Holloway,et al. Postnatal Expansion of the Pancreatic β-Cell Mass Is Dependent on Survivin , 2008, Diabetes.
[4] A. Foulis. Pancreatic pathology in type 1 diabetes in human. , 2008, Novartis Foundation symposium.
[5] Marian Rewers,et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes , 2007, Proceedings of the National Academy of Sciences.
[6] M. Rewers,et al. Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. , 2007, The Journal of clinical endocrinology and metabolism.
[7] U. Bhanot,et al. [Parenchymal regression in chronic pancreatitis spares islets reprogrammed for expression of NFkappaB and IAPs]. , 2006, Verhandlungen der Deutschen Gesellschaft fur Pathologie.
[8] U. Bhanot,et al. Parenchymal regression in chronic pancreatitis spares islets reprogrammed for the expression of NFκB and IAPs , 2005, Laboratory Investigation.
[9] G. Eisenbarth,et al. The stages of type 1A diabetes: 2005 , 2005, Immunological reviews.
[10] M. Löhr,et al. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic Type 1 (insulin-dependent) diabetes mellitus and microangiopathy , 1987, Diabetologia.
[11] C. Liddle,et al. The histopathology of the pancreas in Type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom , 1986, Diabetologia.
[12] Å. Lernmark,et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. , 2003, The Journal of clinical endocrinology and metabolism.
[13] D. Orlicky,et al. Developmentally Regulated Expression of Survivin in Human Pancreatic Islets , 2003, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[14] Jae-Hyoung Cho,et al. Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea , 2003 .
[15] P. Whelton,et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. , 2003, Journal of the American Society of Nephrology : JASN.
[16] In Kyu Lee,et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. , 2003, The Journal of clinical endocrinology and metabolism.
[17] Neonatal diabetes mellitus due to complete glucokinase deficiency , 2001 .
[18] G. Eisenbarth,et al. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction. , 1989, Clinical immunology and immunopathology.
[19] W. Gepts. Pathologic Anatomy of the Pancreas in Juvenile Diabetes Mellitus , 1965, Diabetes.